ENTITY

CSL (CSL AT)

2
Analysis
Health Care • United States
CSL Limited develops, manufactures, and markets human pharmaceutical and diagnostic products derived from human plasma. The Company provides products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
•15 Aug 2025 11:40

ASX Short Interest Weekly (Aug 8th): Wesfarmers, Infratil, Iluka Resources, Bigtincan, Auswide Bank

We analyzed ASX short interest report for the past week and highlight short interest changes in Wesfarmers, Infratil, Iluka Resources, Bigtincan,...

Logo
601 Views
Share
bullish•S&P/ASX 200
•10 Aug 2025 05:30

S&P/ASX 200 (AS51 Index) Ahead of 12 Aug RBA Decision: Markets Divided, but I Vote for a 35bps Cut

RBA to announce rate decision on 12 Aug, as markets split between 0.25% and 0.50% cuts. Explore potential impact and a unique perspective.

Logo
593 Views
Share
•08 Aug 2025 07:05

ASX Short Interest Weekly (Aug 1st): Ramelius Resources, Bluescope Steel, Boss Energy, Coles

We analyzed ASX short interest report for the past week and highlight short interest changes in Ramelius Resources, Bluescope Steel, Boss Energy,...

Logo
483 Views
Share
•31 Jul 2025 17:00

ASX Short Interest Weekly (Jul 25th): Fortescue, BHP, Aristocrat Leisure, CSL, Bigtincan

We analyzed ASX short interest report for the past week and highlight short interest changes in Fortescue, BHP, Aristocrat Leisure, CSL, Bigtincan.

Logo
500 Views
Share
•25 Jul 2025 11:00•Syndicated

Fortescue Metals Group Ltd - Next Week At A Glance - 28 July-1 Aug 2025

A brief look at important company events and economic data releases next week.

Logo
FNArena
483 Views
Share
x